Cue Biopharma, Inc. (CUE:NASDAQ) closed at $18.46 on October 14, 2026, down 5.70% on the day. The stock trades 59.4% below its 52-week high of $45.50 and 270.6% above its 52-week low of $4.98. Cue Biopharma, Inc. is part of the Health Care sector (Major Pharmaceuticals).
| 5D | 1M | 3M | 6M |
|---|---|---|---|
| -29.25% | -35.94% | -29.58% | +7.65% |
In 251 trading sessions since October 13, 2025, CUE closed higher on 117 days (47%). Its best day was May 1, 2026 (+106.38%) and its worst was April 28, 2026 (-30.54%). The stock moved 10% or more in a single session 46 times. It opened at least 5% above the previous day's high 5 times.
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Find more stocks like CUE with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.